Albert Lowe
Stock Analyst at Craig-Hallum
(0.30)
# 4,074
Out of 4,829 analysts
7
Total ratings
28.57%
Success rate
-25.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Albert Lowe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Initiates: Buy | $6 | $0.95 | +531.38% | 1 | Apr 11, 2025 | |
| SKYE Skye Bioscience | Maintains: Buy | $18 → $14 | $2.05 | +582.93% | 2 | Mar 21, 2025 | |
| SABS SAB Biotherapeutics | Initiates: Buy | $11 | $2.01 | +447.26% | 1 | Oct 9, 2024 | |
| CRDF Cardiff Oncology | Initiates: Buy | $8 | $2.76 | +190.38% | 1 | Sep 6, 2024 | |
| LCTX Lineage Cell Therapeutics | Initiates: Buy | $4 | $0.48 | +734.38% | 1 | Aug 20, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $6 | $0.87 | +592.84% | 1 | May 13, 2024 |
Opus Genetics
Apr 11, 2025
Initiates: Buy
Price Target: $6
Current: $0.95
Upside: +531.38%
Skye Bioscience
Mar 21, 2025
Maintains: Buy
Price Target: $18 → $14
Current: $2.05
Upside: +582.93%
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $2.01
Upside: +447.26%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $2.76
Upside: +190.38%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $0.48
Upside: +734.38%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $0.87
Upside: +592.84%